InvestorsHub Logo
Followers 840
Posts 120470
Boards Moderated 18
Alias Born 09/05/2002

Re: willyw post# 702

Monday, 11/17/2014 2:57:00 PM

Monday, November 17, 2014 2:57:00 PM

Post# of 3202
Curiously, ABBV just started a small phase-2 trial of ABT-450/ABT-267 + Sovaldi in GT3 patients: (http://clinicaltrials.gov/ct2/show/NCT02292719 ). Perhaps this is a signal that the ABT-493/ABT-530 regimen is not all ABBV hoped for in GT3 patients, specifically.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News